Sugi Predict

Sugi Predict / Compounds / Ether

Ether

Ether

SCHEMBL16685384

CCOCC.COS(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 4/20 0.45
▸ ALDH1A1 P00352 7/20 0.44
▸ CYP3A4 P08684 2/20 0.42
▸ CYP2C9 P11712 2/20 0.42
▸ CYP2C19 P33261 2/20 0.42
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ CA3 P07451 1/20 0.42
▸ CA6 P23280 1/20 0.42
▸ CA5A P35218 1/20 0.42
▸ CA7 P43166 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ CA5B Q9Y2D0 1/20 0.42
▸ KMT2A Q03164 2/20 0.41
▸ VDR P11473 1/20 0.41
▸ TLR9 Q9NR96 1/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ LMNA P02545 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27524 0.88 GAA (0.56) GAAALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL9901122 0.88 GAA (0.56) GAAALDH1A1CYP3A4CYP2C9CYP2C19
Tetraethylene Glycol SCHEMBL11668304 0.87 ALDH1A1 (0.42) GAAALDH1A1CYP3A4CYP2C9CYP2C19
Triethylene Glycol SCHEMBL378725 0.87 ALDH1A1 (0.42) GAAALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL27494753 0.87 GAA (0.43) GAAALDH1A1CYP3A4CYP2C9CYP2C19
Phosphine SCHEMBL3419219 0.86 GAA (0.54) GAAALDH1A1CYP3A4CYP2C9CYP2C19
Bromide SCHEMBL30687778 0.86 GAA (0.54) GAAALDH1A1CYP3A4CYP2C9CYP2C19
SCHEMBL20531023 0.86 GAA (0.54) GAAALDH1A1CYP3A4CYP2C9CYP2C19
Hydrochloric Acid SCHEMBL30741454 0.86 GAA (0.54) GAAALDH1A1CYP3A4CYP2C9CYP2C19
Ammonia Solution, Strong SCHEMBL5745515 0.86 GAA (0.54) GAAALDH1A1CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12625134-B2 Complex liquid crystal droplets MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2026-05-12 — — US disclosed
US-9745273-B2 Phenazine derivatives as anti-neoplastic agents and anti-infective agents UNIVERSITETET I OSLO (NO) 2017-08-29 — — US disclosed
EP-3063136-A2 PHENAZINE DERIVATIVES AS ANTI-CANCER AND ANTI-INFECTIVE AGENTS Universitetet I Oslo (NO) 2016-09-07 — — EP disclosed
US-20160251320-A1 Compounds UNIVERSITÉ CLAUDE BERNARD LYON 1 (FR) 2016-09-01 — — US disclosed
WO-2015063516-A2 COMPOUNDS UNIVERSITETET I OSLO (NO) 2015-05-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12625134-B2 Complex liquid crystal droplets MAFG, SFN, FLNB GAA 4883/4885ALDH1A1 4423/4885CYP3A4 3304/4885
US-20160251320-A1 Compounds NISCH, MDN1, PIR GAA 3194/4885ALDH1A1 4618/4885CYP3A4 3527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.